Clinical Features and Changes in Insulin Requirements in People with Type 2 Diabetes Requiring Insulin When Hospitalised with SARS-CoV-2 Infection

Table 2

Comparison between the first (April–March 2020) and second wave of SARS-CoV-2 infection (December 2020–January 2021) of insulin requirements and changes of insulin doses (at discharge and after 6 weeks) in people with known T2DM who required insulin as a new treatment during hospitalisation for SARS-CoV-2 infection.

	1^st wave (n = 39)	2^nd wave (n = 43)	value
Total daily dose at discharge, units/kg	0.39 (0.06–0.84)	0.34 (0.12–0.85)	0.98
% of people still on insulin at discharge	28%	56%	0.03
Total daily dose within 6 weeks of discharge, units/kg	0.23 (0.09–0.74)	0.31 (0.17–0.43)	0.37
% of people still on insulin within 6 weeks of discharge	24%	22%	0.87

Data are shown as % or median (range).